These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 11297412)

  • 1. Internalization of the human N-formyl peptide and C5a chemoattractant receptors occurs via clathrin-independent mechanisms.
    Gilbert TL; Bennett TA; Maestas DC; Cimino DF; Prossnitz ER
    Biochemistry; 2001 Mar; 40(12):3467-75. PubMed ID: 11297412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arrestin binding to the G protein-coupled N-formyl peptide receptor is regulated by the conserved "DRY" sequence.
    Bennett TA; Maestas DC; Prossnitz ER
    J Biol Chem; 2000 Aug; 275(32):24590-4. PubMed ID: 10823817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonist-dependent phosphorylation of N-formylpeptide and activation peptide from the fifth component of C (C5a) chemoattractant receptors in differentiated HL60 cells.
    Tardif M; Mery L; Brouchon L; Boulay F
    J Immunol; 1993 Apr; 150(8 Pt 1):3534-45. PubMed ID: 8468487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of N-formyl peptide-mediated degranulation by receptor phosphorylation.
    Vines CM; Xue M; Maestas DC; Cimino DF; Prossnitz ER
    J Immunol; 2002 Dec; 169(12):6760-6. PubMed ID: 12471107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NH2-terminal region of C5aR but not that of FPR is critical for both protein transport and ligand binding.
    Mery L; Boulay F
    J Biol Chem; 1994 Feb; 269(5):3457-63. PubMed ID: 8106386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential roles of the NPXXY motif in formyl peptide receptor signaling.
    He R; Browning DD; Ye RD
    J Immunol; 2001 Mar; 166(6):4099-105. PubMed ID: 11238659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of C5a and formyl peptide receptor expression on human polymorphonuclear leukocytes.
    Van Epps DE; Simpson S; Bender JG; Chenoweth DE
    J Immunol; 1990 Feb; 144(3):1062-8. PubMed ID: 2295813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple activation steps of the N-formyl peptide receptor.
    Prossnitz ER; Gilbert TL; Chiang S; Campbell JJ; Qin S; Newman W; Sklar LA; Ye RD
    Biochemistry; 1999 Feb; 38(8):2240-7. PubMed ID: 10029516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of key serine residues is required for internalization of the complement 5a (C5a) anaphylatoxin receptor via a beta-arrestin, dynamin, and clathrin-dependent pathway.
    Braun L; Christophe T; Boulay F
    J Biol Chem; 2003 Feb; 278(6):4277-85. PubMed ID: 12464600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexras1/AGS-1 inhibits signal transduction from the Gi-coupled formyl peptide receptor to Erk-1/2 MAP kinases.
    Graham TE; Prossnitz ER; Dorin RI
    J Biol Chem; 2002 Mar; 277(13):10876-82. PubMed ID: 11751935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin primes responsiveness of selective chemoattractant receptors at a site distal to G protein activation.
    Ali H; Tomhave ED; Richardson RM; Haribabu B; Snyderman R
    J Biol Chem; 1996 Feb; 271(6):3200-6. PubMed ID: 8621721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine production by G protein-coupled receptor activation in a human mast cell line: roles of extracellular signal-regulated kinase and NFAT.
    Ali H; Ahamed J; Hernandez-Munain C; Baron JL; Krangel MS; Patel DD
    J Immunol; 2000 Dec; 165(12):7215-23. PubMed ID: 11120854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of secretin receptor internalization differ from those of the beta(2)-adrenergic receptor.
    Walker JK; Premont RT; Barak LS; Caron MG; Shetzline MA
    J Biol Chem; 1999 Oct; 274(44):31515-23. PubMed ID: 10531354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficient homologous desensitization of formyl peptide receptors stably expressed in undifferentiated HL-60 cells.
    Rane MJ; Prossnitz ER; Arthur JM; Ward RA; McLeish KR
    Biochem Pharmacol; 2000 Jul; 60(2):179-87. PubMed ID: 10825462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in phosphorylation of formylpeptide and C5a chemoattractant receptors correlate with differences in desensitization.
    Ali H; Richardson RM; Tomhave ED; Didsbury JR; Snyderman R
    J Biol Chem; 1993 Nov; 268(32):24247-54. PubMed ID: 8226971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylation of the N-formyl peptide receptor is required for receptor internalization but not chemotaxis.
    Hsu MH; Chiang SC; Ye RD; Prossnitz ER
    J Biol Chem; 1997 Nov; 272(47):29426-9. PubMed ID: 9367998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human complement 5a (C5a) anaphylatoxin receptor (CD88) phosphorylation sites and their specific role in receptor phosphorylation and attenuation of G protein-mediated responses. Desensitization of C5a receptor controls superoxide production but not receptor sequestration in HL-60 cells.
    Christophe T; Rabiet MJ; Tardif M; Milcent MD; Boulay F
    J Biol Chem; 2000 Jan; 275(3):1656-64. PubMed ID: 10636859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unmasking different constitutive activity of four chemoattractant receptors using Na+ as universal stabilizer of the inactive (R) state.
    Seifert R; Wenzel-Seifert K
    Recept Channels; 2001; 7(5):357-69. PubMed ID: 11697079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single amino acid substitution (N297A) in the conserved NPXXY sequence of the human N-formyl peptide receptor results in inhibition of desensitization and endocytosis, and a dose-dependent shift in p42/44 mitogen-activated protein kinase activation and chemotaxis.
    Gripentrog JM; Jesaitis AJ; Miettinen HM
    Biochem J; 2000 Dec; 352 Pt 2(Pt 2):399-407. PubMed ID: 11085933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-desensitization of chemoattractant receptors occurs at multiple levels. Evidence for a role for inhibition of phospholipase C activity.
    Richardson RM; Ali H; Tomhave ED; Haribabu B; Snyderman R
    J Biol Chem; 1995 Nov; 270(46):27829-33. PubMed ID: 7499254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.